The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

被引:121
作者
Swigris, Jeffrey J. [1 ,2 ]
Wamboldt, Frederick S. [3 ]
Behr, Juergen [4 ]
du Bois, Roland M. [1 ,2 ]
King, Talmadge E. [5 ]
Raghu, Ganesh [6 ]
Brown, Kevin K. [1 ,2 ]
机构
[1] Natl Jewish Hlth, Interstitial Lung Dis Program, Denver, CO 80206 USA
[2] Natl Jewish Hlth, Autoimmune Lung Ctr, Denver, CO 80206 USA
[3] Natl Jewish Hlth, Div Psychosocial Med, Denver, CO USA
[4] Univ Munich, Dept Internal Med 1, D-80539 Munich, Germany
[5] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
[6] Univ Washington, Div Pulm & Crit Care Med, Washington, DC USA
关键词
QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; PROGNOSTIC VALUE; 6-MINUTE WALK; REPRODUCIBILITY; SURVIVAL; TESTS;
D O I
10.1136/thx.2009.113498
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale The response characteristics of the 6 minute walk test (6MWT) in studies of idiopathic pulmonary fibrosis (IPF) are only poorly understood, and the change in walk distance that constitutes the minimum important difference (MID) over time is unknown. Objectives To examine changes over time in distance walked (ie, 6MWD) during the 6MWT and to estimate the change in distance that constitutes the MID in patients with IPF. Methods Data from a recently completed trial that included subjects with IPF who completed the 6MWT, Saint George's Respiratory Questionnaire (SGRQ) and forced vital capacity (FVC) at 6 and 12 months were used to examine longitudinal changes in 6MWD. Both anchor- and distribution-based approaches as well as linear regression analyses were used to determine the MID for 6MWD. The SGRQ Total score and FVC were used as clinical anchors. Main results Among 123 subjects alive and able to complete the 6MWT at both follow-up time points, 6MWD did not change significantly over time (378.1 m at baseline vs 376.8 m at 6 months vs 361.3 m at 12 months, p=0.5). The point estimate for the 6MWD MID was 28 m with a range of 10.8-58.5 m. Conclusion In a group of patients with IPF with moderate physiological impairment, for those alive and able to complete a 6MWT, 6MWD does not change over 12 months. At the population level, the MID for 6MWD appears to be similar to 28 m. Further investigation using other anchors and derivation methods is required to refine estimates of the MID for 6MWD in this patient population.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 37 条
[1]  
ABRAMS D, 1976, J GERONTOL, V24, P470
[2]  
[Anonymous], 1988, STAT ANAL BEHAV SCI
[3]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[4]   Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis [J].
Azuma, A ;
Nukiwa, T ;
Tsuboi, E ;
Suga, M ;
Abe, S ;
Nakata, K ;
Taguchi, Y ;
Nagai, S ;
Itoh, H ;
Ohi, M ;
Sato, A ;
Kudoh, S ;
Raghu, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) :1040-1047
[5]   2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608
[6]   A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis [J].
Clark, M ;
Cooper, B ;
Singh, S ;
Cooper, M ;
Carr, A ;
Hubbard, R .
THORAX, 2001, 56 (06) :482-486
[7]   Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis [J].
Collard, HR ;
King, TE ;
Bartelson, BB ;
Vourlekis, JS ;
Schwarz, MI ;
Brown, KK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :538-542
[8]  
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185
[9]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[10]  
DUBOIS RM, 2008, CHEST, V134